Enso Discoveries, LLC – Trademark Portfolio
Entity Type: 16
Enso Discoveries, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REBOUND PRP. The owner is based in Manhattan, KS.
2017 Vanesta Place, Suite 118
Manhattan, KS 66503
Showing of trademarks Trademarks
Trademark Classifications
Enso Discoveries, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Enso Discoveries, LLC have?
Enso Discoveries, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 3 cancelled.
What trademark classes does Enso Discoveries, LLC file in?
Enso Discoveries, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Enso Discoveries, LLC's most well-known trademarks?
Enso Discoveries, LLC's registered trademark portfolio includes well-known marks such as REBOUND PRP. These are among 1 currently registered trademark in the portfolio.
What is Enso Discoveries, LLC's trademark registration success rate?
Enso Discoveries, LLC has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.